Dimethyl Fumarate Attenuates Cyclophosphamide‐Induced Bladder Damage and Enhances Cytotoxic Activity Against SH‐SY5Y Cells
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Elif Nur Barut und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Karadeniz Technical University, Trabzon, Turkiye. Hauptthemen laut MEDLINE: Dimethyl Fumarate, Cyclophosphamide, Urinary Bladder, Cystitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cylophosphamide (CP)‐induced acute cystitis is a debilitating bladder dysfunction commonly observed in cancer patients, primarily resulting from oxidative damage and inflammation in the bladder tissue. Dimethyl fumarate (DMF) is a fumaric acid ester approved for the treatment of multiple sclerosis due to its antioxidant and anti‐inflammatory properties. Thus, we aimed to investigate the multiple effects of DMF, involving both its potential synergistic effect with CP on the SH‐SY5Y cells and its uroprotective effect on CP‐induced acute cystitis. Female Balb/c mice were orally administrated DMF (100 or 300 mg/kg/day) for five consecutive days before a single intraperitoneal (i.p) dose of CP. Mesna was administered 20 min before and at 4 h, 8 h after CP application. Following 24 h of CP injection, bladders were removed for functional, biochemical analysis and evaluation of vesical vascular permeability. SH‐SY5Y cell viability was assayed by MTT test. CP markedly decreased carbachol‐induced contraction of detrusor strips ( p < 0.01), which was prevented by the high‐dose DMF treatment ( p < 0.05). Evans blue dye extravasation was greatly increased in the bladders of cystitis group ( p < 0.001), which was significantly decreased in DMF‐treated mice with cystitis ( p < 0.01). Total GSH content was decreased ( p < 0.01) whereas TNF‐α level was increased ( p < 0.05) in the bladders of cystitis group. High‐dose DMF‐treated mice showed an increment in total GSH content ( p < 0.05) without any alterations on TNF‐α levels of the bladders with cystitis. Additionally, combination of different concentrations of CP and DMF exhibited a potent synergistic cytotoxic effect in SH‐SY5Y cells. DMF improved CP‐induced acute cystitis by partially suppressing oxidative stress and inflammation, while also enhancing the cytotoxic effects of CP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, Karadeniz Technical University, Trabzon, Turkiye.
- Department of Pharmaceutical Toxicology, Acıbadem Mehmet Ali Aydınlar University Faculty of Pharmacy, İstanbul, Turkiye.
- Department of Pharmaceutical Toxicology, Istanbul University Institute of Health Science, İstanbul, Turkiye.
Zitieren
APA
Barut, E. N., Engin, S., Öz, E., & Reis, R. (2025). Dimethyl Fumarate Attenuates Cyclophosphamide‐Induced Bladder Damage and Enhances Cytotoxic Activity Against SH‐SY5Y Cells. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70212
Vancouver
Barut EN, Engin S, Öz E, Reis R. Dimethyl Fumarate Attenuates Cyclophosphamide‐Induced Bladder Damage and Enhances Cytotoxic Activity Against SH‐SY5Y Cells. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70212
BibTeX
@article{Barut2025,
author = {Barut, Elif Nur and Engin, Seçkin and Öz, Elif and Reis, Rengin},
title = {Dimethyl Fumarate Attenuates Cyclophosphamide‐Induced Bladder Damage and Enhances Cytotoxic Activity Against SH‐SY5Y Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70212}
}
EUVIMED